Department of Medicine, Washington University School of Medicine, St Louis, Missouri, USA.
Clin Infect Dis. 2012 Aug;55 Suppl 2(Suppl 2):S88-92. doi: 10.1093/cid/cis335.
There are few high-quality studies of the costs of Clostridium difficile infection (CDI), and the majority of studies focus on the costs of CDI in acute-care facilities. Analysis of the best available data, from 2008, indicates that CDI may have resulted in $4.8 billion in excess costs in US acute-care facilities. Other areas of CDI-attributable excess costs that need to be investigated are costs of increased discharges to long-term care facilities, of CDI with onset in long-term care facilities, of recurrent CDI, and of additional adverse events caused by CDI.
关于艰难梭菌感染（CDI）的成本，高质量的研究甚少，且大多数研究都集中在急性护理机构中 CDI 的成本上。对 2008 年最佳可用数据的分析表明，CDI 可能导致美国急性护理机构的超额成本达到 48 亿美元。需要进一步研究的其他与 CDI 相关的超额成本领域包括：长期护理机构中 CDI 发病的成本、长期护理机构中 CDI 的复发成本、以及由 CDI 引起的其他不良事件的成本。
